Nathalie Largeron
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Opportunities for and Challenges of Conducting Indirect Treatment Comparisons and Meta-Analyses for Vaccines in Post-EU HTA Regulation Era.
Journal: Journal of market access & health policy
Published: December 19, 2024
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report.
Journal: International journal of technology assessment in health care
Published: May 16, 2024
Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force report.
Journal: International journal of technology assessment in health care
Published: May 10, 2024
Guiding Principles for Evaluating Vaccines in Joint Health Technology Assessment in the European Union: Preparing for the European Union's Regulation on Health Technology Assessment for Vaccines.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: February 07, 2024
Estimated health and economic impact of using high-dose influenza vaccine on respiratory and circulatory plus respiratory hospitalizations of older adults in Australia.
Journal: Vaccine: X
Published: April 26, 2023
Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales.
Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales.
Journal: Journal of medical economics
Published: November 02, 2021
Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy.
Journal: Cost effectiveness and resource allocation : C/E
Published: August 05, 2016
An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: July 02, 2016
Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.
Journal: Human vaccines & immunotherapeutics
Published: May 12, 2016
Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend.
Journal: BMC public health
Published: March 12, 2016
Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria.
Journal: BMC infectious diseases
Published: November 27, 2015
Last Updated: 09/26/2026